China and Japan to hold maritime dialogue despite espionage allegations and executive arrest.
TL;DR Summary
The CEO of Japanese pharmaceutical company Eisai has ruled out exiting the Chinese market following the arrest of a Chinese executive on suspicion of spying. The company will instead focus on strengthening its compliance and risk management systems in China. Eisai has been operating in China for over 30 years and sees the country as a key market for growth.
- Japanese pharma boss rules out China exit after executive's arrest Financial Times
- Chinese ambassador to Japan says Beijing has solid evidence of spying by Astellas employee The Japan Times
- China-Japan's 15th round of maritime affairs consultations set for Tokyo on April 10 Reuters
- China and Japan to hold high-level maritime dialogue in Tokyo on Monday The Japan Times
Reading Insights
Total Reads
1
Unique Readers
10
Time Saved
0 min
vs 1 min read
Condensed
49%
117 → 60 words
Want the full story? Read the original article
Read on Financial Times